Close
CDMO Safety Testing 2026
Novotech

Inspirata Hosts Fireside Chat on the Future of Pathology in a Post-COVID-19 World

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi

Eli Lilly and Company and Hanmi Pharm have officially...

Pharmacogenomics in 2026: From Research Concept to Clinical Workflow

Pharmacogenomics has moved well beyond the research phase. In...

Pfizer and Innovent Finalize $10.5 Billion Global Oncology Agreement

The Pfizer Innovent Cancer Deal has been finalized, establishing...
- Advertisement -

Cancer informatics and digital pathology solution provider Inspirata is setting its sights on the post-COVID-19 future.

Following the drastic social distancing measures implemented across the world, Inspirata announced its COVID-19 Free Remote Pathology Initiative in March, which allows healthcare institutions affected by the pandemic to use the companyโ€™s pathology workflow software and digital services free of charge for the duration of the crisis. Recognizing the changing needs of healthcare institutions as the pandemic situation evolves, Inspirata is now adding to this initiative an industry-wide discussion on what a post-pandemic world will look like for the pathology profession.

Inspirata has assembled a cross-functional panel of experts, both on the clinical and business side, who will join for a virtual fireside chat on May 12th to discuss the expected challenges facing pathology departments as they begin to resume normal operations, as well as the planned actions to help remedy these challenges.

“The current pandemic has posed significant challenges to the Pathology profession. A poll we ran in March showed nearly 50% of pathology departments feeling poorly prepared to offer remote functionality to their staff in light of COVID-19. As the conversation now shifts to preparing to go back to normal schedules in a post-pandemic world, we find many are still lagging in their plans. According to early survey results, only 30% of organizations have done significant planning for post-COVID-19 scenarios. Iโ€™m thrilled to be joined by a panel of distinguished industry leaders to discuss this important topic. I look forward to a very open and engaged conversation with professionals joining our fireside chat from multiple backgrounds and geographies,” states Mark Lloyd, PhD, EVP and Founder of Inspirata, who will be moderating the May 12th fireside chat.

Inspirata invites all interested pathology professionals and healthcare leaders to join the conversation on this important topic. The virtual fireside chat is open for registration, free of charge. Everyone who signs up as a participant can propose a question to be added to the panel discussion.

About Inspirata
Inspirata, Inc. helps patients fighting cancer โ€“ and the clinicians they trust โ€“ to make every moment matter. Our comprehensive cancer informatics solutions bring disparate data together throughout the entire cancer care journey to drive informed decisions that improve survivorship.

Inspirata has assembled the most advanced and proven technologies to address the complex challenges of delivering cancer care and conducting ground-breaking research. We combine leading digital pathology solutions with automated cancer registry solutions, comprehensive cancer informatics and advanced patient engagement tools to bring users the broadest oncology informatics platform available globally.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi

Eli Lilly and Company and Hanmi Pharm have officially...

Pharmacogenomics in 2026: From Research Concept to Clinical Workflow

Pharmacogenomics has moved well beyond the research phase. In...

Pfizer and Innovent Finalize $10.5 Billion Global Oncology Agreement

The Pfizer Innovent Cancer Deal has been finalized, establishing...

The Push for Greater Accuracy in Clinical Trials

Clinical trials are the foundation of modern medicine. Every...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป